Loading…
Kestra Medical Technologies, Ltd. is projected to rise to $33.16 by 2027, a +28% move from its current price of $25.99. KMTS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $25.12 | $26.01 | $26.93 | +0.08% |
| Jul 13 | $24.78 | $26.03 | $27.34 | +0.16% |
| Jul 14 | $24.53 | $26.05 | $27.67 | +0.24% |
| Jul 15 | $24.32 | $26.07 | $27.95 | +0.32% |
| Jul 16 | $24.15 | $26.09 | $28.20 | +0.40% |
| Jul 17 | $23.99 | $26.11 | $28.43 | +0.48% |
| Jul 18 | $23.84 | $26.14 | $28.65 | +0.56% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $23.84 | $26.14 | $28.65 | +0.56% |
| Week 2 | $23.08 | $26.28 | $29.93 | +1.12% |
| Week 3 | $22.54 | $26.43 | $30.98 | +1.69% |
| Week 4 | $22.12 | $26.58 | $31.93 | +2.26% |
| Week 5 | $21.76 | $26.73 | $32.82 | +2.83% |
| Week 6 | $21.46 | $26.87 | $33.65 | +3.41% |
| Week 7 | $21.20 | $27.03 | $34.46 | +3.98% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Kestra Medical Technologies, Ltd. is a healthcare company that operates as a wearable medical device and digital healthcare provider. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected.
The company develops and commercializes the Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its platform provides ASSURE WCD, a wearable cardioverter defibrillator used to protect patients at an elevated risk of sudden cardiac arrest; and a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes. Kestra was founded in 2014 and is based in Kirkland, Washington.
Kestra Medical Technologies, Ltd. (KMTS) is a healthcare stock with a current price of $26.43 and a market capitalization of $1.54B. It ranks 2234 in market cap terms.
The price outlook is characterized by a long-term forecast path where the average price rises from $26.43 in 2026 to $208.57 by 2050, with a max forecast of $438.47 in 2050. The forecast suggests a bullish trajectory in the long run, with a neutral stance in 2026 and bullish sentiment in most subsequent years.
A major floor 41.6% below — a decisive break under it would weaken the trend.
The nearest floor, 27.6% below — buyers have tended to step in here.
The nearest ceiling, 7.3% above — a clean break opens room to run.
A major ceiling 28.1% above — clearing it would confirm fresh momentum.
Key KMTS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of KMTS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $27.04 | Sell | $26.53 | Sell |
| MA 10 | $26.57 | Sell | $25.89 | Buy |
| MA 20 | $23.57 | Buy | $24.42 | Buy |
| MA 50 | $21.79 | Buy | $22.71 | Buy |
| MA 100 | $21.75 | Buy | $22.40 | Buy |
| MA 200 | $23.59 | Buy | $22.43 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 61.52 | Neutral |
| Stoch RSI (14) | 42.93 | Neutral |
| CCI (20) | 53.79 | Neutral |
| Williams %R (14) | -26.29 | Info |
| MACD (12,26,9) | 0.29 | Buy |
| ROC (12) | 25.62 | Buy |
| Bollinger %B (20,2) | 0.69 | Neutral |
| Stochastic %K (14) | 73.71 | Neutral |
| TRIX (15) | 0.96 | Buy |
| Awesome (5,34) | 4.79 | Buy |
| Ultimate (7,14,28) | 62.32 | Neutral |
| Momentum (10) | 3.41 | Buy |
| Aroon Osc (25) | 84.00 | Buy |
| Hull MA (9) | 26.90 | Sell |
| ADX (14) | 24.26 | Buy |
| ATR (14) | 0.75 | Info |
The 30-day technical picture is bullish overall. RSI14 is 60, with the stock trading above both the SMA50 of $20.94 and the SMA200 of $23.37, indicating constructive near-term momentum.
Support is at $18.82 and resistance at $22.58, with a 30-day range of $21.15 to $33.03. Annualized volatility is 60%, highlighting elevated near-term variability even as momentum remains positive.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $17.87 | $25.99 | $37.43 | 0% | Neutral | |
| $25.50 | $33.16 | $46.14 | +28% | Bullish | |
| $32.54 | $44.04 | $64.29 | +69% | Bullish | |
| $38.16 | $53.39 | $80.90 | +105% | Bullish | |
| $40.14 | $57.86 | $90.44 | +123% | Bullish | |
| $41.15 | $60.96 | $97.87 | +135% | Bullish | |
| $40.44 | $61.47 | $101.09 | +137% | Bullish | |
| $45.37 | $70.65 | $118.74 | +172% | Bullish | |
| $51.77 | $82.51 | $141.46 | +217% | Bullish | |
| $58.01 | $94.55 | $165.10 | +264% | Bullish | |
| $68.29 | $123.49 | $232.73 | +375% | Bullish | |
| $149.72 | $327.04 | $687.49 | +11.6x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $17.87 | $25.99 | $31.12 | +0.00% |
| August 2026 | $21.89 | $26.10 | $32.15 | +0.43% |
| September 2026 | $23.21 | $27.95 | $34.94 | +7.08% |
| October 2026 | $23.95 | $29.08 | $36.81 | +4.04% |
| November 2026 | $23.40 | $28.61 | $36.59 | -1.62% |
| December 2026 | $23.55 | $28.99 | $37.43 | +1.32% |
Click any year to see its month-by-month KMTS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect KMTS to range from $17.87 to $37.43 through 2026. The $25.99 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The KMTS price prediction for 2027 points to an average of $33.16 (low $25.50, high $46.14) — a potential gain of +28% on today's $25.99. Buyers look set to stay in control over this stretch.
In 2028, KMTS is projected to trade between $32.54 and $64.29, averaging $44.04 — a potential gain of +69% from today's $25.99. That is up +33% on the projected 2027 average. Momentum favours further upside here.
Kestra Medical Technologies, Ltd.'s 2029 outlook centres on $53.39, within a $38.16 to $80.90 range. That is up +21% on the projected 2028 average. That marks a +105% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, KMTS could reach as high as $90.44, with a base case around $57.86 and support toward $40.14 — roughly +123% from $25.99. Momentum favours further upside here.
Expect KMTS to range from $41.15 to $97.87 through 2031. The $60.96 average target implies a +135% move from current prices. That is up +5% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The KMTS price prediction for 2032 points to an average of $61.47 (low $40.44, high $101.09) — a potential gain of +137% on today's $25.99. Momentum favours further upside here.
In 2033, KMTS is projected to trade between $45.37 and $118.74, averaging $70.65 — a potential gain of +172% from today's $25.99. That is up +15% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Kestra Medical Technologies, Ltd.'s 2034 outlook centres on $82.51, within a $51.77 to $141.46 range. That is up +17% on the projected 2033 average. That marks a +217% change versus current levels. Momentum favours further upside here.
By 2035, KMTS could reach as high as $165.10, with a base case around $94.55 and support toward $58.01 — roughly +264% from $25.99. Buyers look set to stay in control over this stretch.
Expect KMTS to range from $68.29 to $232.73 through 2040. The $123.49 average target implies a +375% move from current prices. That is up +31% on the projected 2035 average. Momentum favours further upside here.
The KMTS price prediction for 2050 points to an average of $327.04 (low $149.72, high $687.49) — a potential gain of +11.6x on today's $25.99. Buyers look set to stay in control over this stretch.
Investing $1,000 in KMTS today (≈ 38.476337 KMTS) could be worth
$12,583.31
+$11,583.31 (+1158%) by 2050 · US Dollar
Based on the average projected KMTS price of $327.04 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in KMTSwould be worth at today's price.
$1,000 invested in KMTS on Jul 10, 2025 (≈ 65.832787 KMTS) would be worth
$1,710.99
+$710.99 (+71.1%) today · 1.71× · US Dollar
Based on a KMTS entry price of $15.19 vs. today's $25.99.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $26.98 | $963.31 | -3.7% |
| 1 month ago | $19.44 | $1,336.93 | +33.7% |
| 3 months ago | $17.87 | $1,454.39 | +45.4% |
| 6 months ago | $23.41 | $1,110.21 | +11.0% |
| 1 year ago | $15.19 | $1,710.99 | +71.1% |
| All time (1.3y) ago | $21.84 | $1,190.02 | +19.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our KMTS forecast.
Our base-case forecast reaches $52.00 around 2029.
Implied market cap at $52.00: $3.04B
Over the multi-year horizon, the forecast shows a pronounced uplift in average prices. The 2027 forecast average is $30.27 (min $23.24, max $42.20) with ROI 14.5 and neutral sentiment, followed by 2028 avg $38.16 (min $28.16, max $55.78) ROI 44.4 and bullish sentiment. The path continues higher through 2029 avg $46.78 (min $33.40, max $70.96) ROI 77 and bullish sentiment, then 2030 avg $47.79 (min $33.12, max $74.75) ROI 80.8 and bullish sentiment.
From 2031 to 2035 the averages rise to $48.87, $50.13, $53.45, and $59.24 respectively, with ROI progressing to 84.9%, 89.7%, 102.2%, and 124.2% while maintaining bullish sentiment. The trajectory extends to 2040 with avg $83.69 (min $46.27, max $157.77) ROI 216.7 and bullish sentiment, and culminates in 2050 with avg $208.57 (min $95.48, max $438.47) ROI 689.1 and bullish sentiment. These are estimates, not guarantees, and reflect uncertainties and market conditions inherent in long-term forecasts.
Tap a question to reveal the answer.
Avg $47.79, min $33.12, max $74.75; ROI 80.8%; sentiment BULLISH.
The forecast shows a path of rising averages and bullish sentiment from 2028 onward, with the 2050 average at $208.57 and ROI 689.1%; however, these are estimates, not guarantees, and later-year results depend on market conditions.
Yes. The 2034 max is $101.62 and the 2035 max is $119.87, indicating potential to exceed $100 in the forecast horizon.
Avg $83.69; min $46.27; max $157.77; ROI 216.7; sentiment BULLISH.
Avg $208.57; min $95.48; max $438.47; ROI 689.1; sentiment BULLISH.
Kestra Medical Technologies, Ltd. Community Discussion
0Share your Kestra Medical Technologies, Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.